Vanguard Group Inc

13F Holdings History for OptimizeRx Corp - Common Stock (OPRX)

Symbol: OPRX on Nasdaq
Investment type: Equity / Common Stock
Latest Disclosed Ownership: 922K shares
Security Ownership: 4.98%

Shares, Excluding Options vs Price

Value, Excluding Options

The Vanguard Group ownership in OptimizeRx Corp Common Stock (OPRX)

2025-04-30 - The Vanguard Group has filed an SCHEDULE 13G/A form with the Securities and Exchange Commission (SEC) disclosing ownership of 922K shares of OptimizeRx Corp Common Stock (OPRX). This represents 4.98% percent ownership of the company.

Reporting Name	Ownership %	Change	Value $	Shares owned	Change	Activity %	Price	Form	Report date	Filed at
The Vanguard Group	4.98%		$7.14M	922K			$7.75	13G/A	3/31/2025	30 Apr 2025 11:22:15

Holdings date	Weight	Change	Value $	Shares	Change	Activity %	Price	All Holders
6/30/2025	0%		$12.4M	921K	-963	-0.1%	$13.50	Q2 2025
3/31/2025	0%	0%	$7.98M	922K	-13,709		$8.66	Q1 2025
12/31/2024	0%	0%	$4.55M	936K	-17,336	-1.82%	$4.86	Q4 2024
9/30/2024	0%	0%	$7.36M	953K	-20,675	-2.12%	$7.72	Q3 2024
6/30/2024	0%	0%	$9.74M	974K	-53,725	-5.23%	$10.00	Q2 2024
3/31/2024	0%	+0%	$12.5M	1.03M	+6,291	+0.62%	$12.15	Q1 2024
12/31/2023	0%	+0%	$14.6M	1.02M	+28,416	+2.86%	$14.31	Q4 2023
9/30/2023	0%	+0%	$7.72M	993K	+102,650	+11.5%	$7.78	Q3 2023
6/30/2023	0%	+0%	$12.7M	890K	+21,764	+2.51%	$14.29	Q2 2023
3/31/2023	0%	0%	$12.7M	868K	-243,239	-21.9%	$14.63	Q1 2023
12/31/2022	0%	+0%	$18.7M	1.11M	+104,999	+10.4%	$16.80	Q4 2022
9/30/2022	0%	0%	$14.9M	1.01M	-78,052	-7.2%	$14.82	Q3 2022
6/30/2022	0%	0%	$29.7M	1.08M	-30,622	-2.75%	$27.39	Q2 2022
3/31/2022	0%	+0%	$42M	1.12M	+32,310	+2.98%	$37.71	Q1 2022
12/31/2021	0%	+0%	$67.3M	1.08M	+264,570	+32.3%	$62.11	Q4 2021
9/30/2021	0%	+0%	$70M	818K	+43,857	+5.66%	$85.55	Q3 2021
6/30/2021	0%	+0%	$47.9M	774K	+86,181	+12.5%	$61.90	Q2 2021
3/31/2021	0%	+0%	$33.5M	688K	+51,991	+8.17%	$48.75	Q1 2021
12/31/2020	0%	+0%	$19.8M	636K	+59,903	+10.4%	$31.16	Q4 2020
9/30/2020	0%	+0%	$12M	576K	+14,339	+2.55%	$20.85^*	Q3 2020
6/30/2020	0%	0%	$7.32M	562K	-115,392	-17%	$13.03	Q2 2020
3/31/2020	0%	+0%	$6.14M	677K	+18,619	+2.83%	$9.06^*	Q1 2020
12/31/2019	0%	+0%	$6.77M	659K	+69,591	+11.8%	$10.27	Q4 2019
9/30/2019	0%	+0%	$8.53M	589K	+78,057	+15.3%	$14.48	Q3 2019
6/30/2019	0%	+0%	$8.28M	511K	+93,015	+22.2%	$16.20	Q2 2019
3/31/2019	0%	+0%	$5.32M	418K	+23,479	+5.95%	$12.72	Q1 2019
12/31/2018	0%	+0%	$4.33M	395K	+105,443	+36.5%	$10.97	Q4 2018
9/30/2018	0%	+0%	$5.2M	289K	+289,123	NEW	$18.00	Q3 2018

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.